Screener
NeoGenomics NEO Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from NeoGenomics’s reported figures.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| NET REVENUE | $201,656 | $181,330 | $388,328 | $349,365 |
| COST OF REVENUE | 109,778 | 104,072 | 215,586 | 198,861 |
| GROSS PROFIT | 91,878 | 77,258 | 172,742 | 150,504 |
| Operating expenses: | ||||
| General and administrative | 63,613 | 71,747 | 129,354 | 139,954 |
| Research and development | 10,761 | 9,023 | 20,295 | 19,204 |
| Sales and marketing | 27,275 | 24,075 | 51,105 | 46,758 |
| Impairment charges (Note 5) | — | 20,041 | — | 20,041 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's gross profit?
- NeoGenomics (NEO) reported gross profit of $91.88M in Q2 2026.
- How has NeoGenomics's gross profit changed year-over-year?
- NeoGenomics's gross profit increased by 18.9% year-over-year, from $77.26M to $91.88M.
- What is the long-term trend for NeoGenomics's gross profit?
- Over 4 years (2021 to 2025), NeoGenomics's gross profit has grown at a 13.9% compound annual growth rate (CAGR), from $187.06M to $314.29M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about NeoGenomics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude